Hikma Pharmaceuticals (LON:HIK) Earns “Buy” Rating from Jefferies Financial Group

Hikma Pharmaceuticals (LON:HIK)‘s stock had its “buy” rating reissued by analysts at Jefferies Financial Group in a research note issued on Thursday, Digital Look reports. They currently have a GBX 2,025 target price on the stock. Jefferies Financial Group‘s price objective would indicate a potential upside of 21.77% from the stock’s previous close.

Other analysts have also recently issued reports about the company. Citigroup lifted their price target on Hikma Pharmaceuticals from GBX 1,700 to GBX 1,870 and gave the stock a “buy” rating in a report on Wednesday, August 12th. Berenberg Bank upped their price objective on Hikma Pharmaceuticals from GBX 1,800 to GBX 2,100 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,950 target price on shares of Hikma Pharmaceuticals in a research note on Friday, August 7th. Six investment analysts have rated the stock with a Buy rating. According to MarketBeat.com, Hikma Pharmaceuticals currently has a consensus rating of “Buy” and a consensus price target of GBX 2,085.83.

Hikma Pharmaceuticals Stock Performance

LON HIK opened at GBX 1,663 on Thursday. Hikma Pharmaceuticals has a 1 year low of GBX 1,187 and a 1 year high of GBX 1,762. The firm has a market capitalization of £3.44 billion, a P/E ratio of 9.45, a price-to-earnings-growth ratio of 2.38 and a beta of 0.65. The firm’s fifty day moving average price is GBX 1,626.31 and its two-hundred day moving average price is GBX 1,507.66. The company has a current ratio of 1.98, a quick ratio of 1.27 and a debt-to-equity ratio of 77.57.

Insider Activity

In related news, insider Tobias Hestler bought 7,500 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were bought at an average price of GBX 1,648 per share, for a total transaction of £123,600. 22.26% of the stock is owned by insiders.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly. We are a trusted, reliable partner and dependable source of over 820+ (as of Feb 2026) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe.